A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | AA | AB | AC | AD | AE | AF | AG | AH | AI | AJ | AK | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Helen Keller International | Helen Keller International | Helen Keller International | Nutrition International | ||||||||||||||||||||||||||||||||||
2 | Burkina Faso | Cameroon | Côte d'Ivoire | DRC | Guinea | Kenya | Madagascar | Mali | Niger | Nigeria | Nigeria | Nigeria | Nigeria | Nigeria | Nigeria | Nigeria | Nigeria | Nigeria | Nigeria | Nigeria | Nigeria | Nigeria | Nigeria | Nigeria | Angola | Chad | Togo | Uganda | ||||||||||
3 | Main calculations | unit | type | Overall | Adamawa | Akwa Ibom | Anambra | Benue | Delta | Ebonyi | Edo | Ekiti | Imo | Kogi | Nasarawa | Ogun | Osun | Rivers | Taraba | |||||||||||||||||||
4 | Final cost-effectiveness estimate (pulled from below for visibility) | xcash | feed | - | 22.4 | 15.8 | 8.5 | 16.8 | 10.9 | 4.8 | 15.8 | 32.6 | 58.9 | 21.3 | 4.4 | 2.3 | 9.5 | 5.2 | 13.4 | 3.8 | 5.9 | 3.1 | 4.2 | 11.9 | 4.8 | 2.3 | 7.6 | 28.7 | 5.6 | 20.0 | 14.8 | 6.3 | ||||||
5 | Costs | |||||||||||||||||||||||||||||||||||||
6 | ||||||||||||||||||||||||||||||||||||||
7 | GiveWell costs | |||||||||||||||||||||||||||||||||||||
8 | Grant size | $ | input | $1,000,000 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | ||||||
9 | ||||||||||||||||||||||||||||||||||||||
10 | Cost breakdown | |||||||||||||||||||||||||||||||||||||
11 | Percentage of total costs covered by the grantee | % | input | - | 43% | 64% | 47% | 47% | 55% | 47% | 60% | 43% | 36% | 47% | 47% | 47% | 47% | 47% | 47% | 47% | 47% | 47% | 47% | 47% | 47% | 47% | 47% | 47% | 70% | 70% | 70% | 70% | ||||||
12 | Percentage of total costs covered by Nutrition International (vitamin A capsule procurement) | % | input | - | 6% | 6% | 7% | 7% | 5% | 7% | 7% | 8% | 8% | 7% | 7% | 7% | 7% | 7% | 7% | 7% | 7% | 7% | 7% | 7% | 7% | 7% | 7% | 7% | 0% | 0% | 0% | 0% | ||||||
13 | Percentage of total costs covered by other philanthropic actors | % | input | - | 6% | 0% | 13% | 13% | 10% | 13% | 0% | 18% | 26% | 13% | 13% | 13% | 13% | 13% | 13% | 13% | 13% | 13% | 13% | 13% | 13% | 13% | 13% | 13% | 0% | 0% | 0% | 0% | ||||||
14 | Percentage of total costs covered by domestic governments (financial contributions) | % | input | - | 15% | 0% | 3% | 3% | 0% | 3% | 3% | 0% | 0% | 3% | 3% | 3% | 3% | 3% | 3% | 3% | 3% | 3% | 3% | 3% | 3% | 3% | 3% | 3% | 0% | 0% | 0% | 0% | ||||||
15 | Percentage of total costs covered by domestic governments (in-kind contributions) | % | input | - | 30% | 30% | 30% | 30% | 30% | 30% | 30% | 30% | 30% | 30% | 30% | 30% | 30% | 30% | 30% | 30% | 30% | 30% | 30% | 30% | 30% | 30% | 30% | 30% | 30% | 30% | 30% | 30% | ||||||
16 | ||||||||||||||||||||||||||||||||||||||
17 | Total costs | |||||||||||||||||||||||||||||||||||||
18 | Total spending by all contributors | $ | calc | - | $2,319,842 | $1,561,670 | $2,145,967 | $2,145,967 | $1,809,082 | $2,145,967 | $1,671,375 | $2,312,317 | $2,764,820 | $2,145,967 | $2,145,967 | $2,145,967 | $2,145,967 | $2,145,967 | $2,145,967 | $2,145,967 | $2,145,967 | $2,145,967 | $2,145,967 | $2,145,967 | $2,145,967 | $2,145,967 | $2,145,967 | $2,145,967 | $1,428,571 | $1,428,571 | $1,428,571 | $1,428,571 | ||||||
19 | ||||||||||||||||||||||||||||||||||||||
20 | Total spending attributable to different actors | |||||||||||||||||||||||||||||||||||||
21 | Total spending contributed by grantee | $ | calc | - | $1,000,000 | $1,000,000 | $1,000,000 | $1,000,000 | $1,000,000 | $1,000,000 | $1,000,000 | $1,000,000 | $1,000,000 | $1,000,000 | $1,000,000 | $1,000,000 | $1,000,000 | $1,000,000 | $1,000,000 | $1,000,000 | $1,000,000 | $1,000,000 | $1,000,000 | $1,000,000 | $1,000,000 | $1,000,000 | $1,000,000 | $1,000,000 | $1,000,000 | $1,000,000 | $1,000,000 | $1,000,000 | ||||||
22 | Total spending contributed by Nutrition International (vitamin A capsule procurement) | $ | calc | - | $148,960 | $93,169 | $149,591 | $149,591 | $88,034 | $149,591 | $116,508 | $195,582 | $218,092 | $149,591 | $149,591 | $149,591 | $149,591 | $149,591 | $149,591 | $149,591 | $149,591 | $149,591 | $149,591 | $149,591 | $149,591 | $149,591 | $149,591 | $149,591 | $0 | $0 | $0 | $0 | ||||||
23 | Total spending contributed by other philanthropic actors | $ | calc | - | $131,162 | $0 | $283,953 | $283,953 | $178,323 | $283,953 | $0 | $423,039 | $717,282 | $283,953 | $283,953 | $283,953 | $283,953 | $283,953 | $283,953 | $283,953 | $283,953 | $283,953 | $283,953 | $283,953 | $283,953 | $283,953 | $283,953 | $283,953 | $0 | $0 | $0 | $0 | ||||||
24 | Total spending contributed by domestic governments (financial contributions) | $ | calc | - | $343,768 | $0 | $68,633 | $68,633 | $0 | $68,633 | $53,454 | $0 | $0 | $68,633 | $68,633 | $68,633 | $68,633 | $68,633 | $68,633 | $68,633 | $68,633 | $68,633 | $68,633 | $68,633 | $68,633 | $68,633 | $68,633 | $68,633 | $0 | $0 | $0 | $0 | ||||||
25 | Total spending contributed by domestic governments (in-kind contributions) | $ | calc | - | $695,953 | $468,501 | $643,790 | $643,790 | $542,725 | $643,790 | $501,412 | $693,695 | $829,446 | $643,790 | $643,790 | $643,790 | $643,790 | $643,790 | $643,790 | $643,790 | $643,790 | $643,790 | $643,790 | $643,790 | $643,790 | $643,790 | $643,790 | $643,790 | $428,571 | $428,571 | $428,571 | $428,571 | ||||||
26 | ||||||||||||||||||||||||||||||||||||||
27 | Upstream / downstream spending | |||||||||||||||||||||||||||||||||||||
28 | Total spending causally upstream of donations to grantee | $ | calc | - | $1,474,930 | $1,000,000 | $1,352,586 | $1,352,586 | $1,178,323 | $1,352,586 | $1,053,454 | $1,423,039 | $1,717,282 | $1,352,586 | $1,352,586 | $1,352,586 | $1,352,586 | $1,352,586 | $1,352,586 | $1,352,586 | $1,352,586 | $1,352,586 | $1,352,586 | $1,352,586 | $1,352,586 | $1,352,586 | $1,352,586 | $1,352,586 | $1,000,000 | $1,000,000 | $1,000,000 | $1,000,000 | ||||||
29 | Total spending causally downstream of donations to grantee | $ | calc | - | $844,913 | $561,670 | $793,381 | $793,381 | $630,759 | $793,381 | $617,920 | $889,277 | $1,047,538 | $793,381 | $793,381 | $793,381 | $793,381 | $793,381 | $793,381 | $793,381 | $793,381 | $793,381 | $793,381 | $793,381 | $793,381 | $793,381 | $793,381 | $793,381 | $428,571 | $428,571 | $428,571 | $428,571 | ||||||
30 | ||||||||||||||||||||||||||||||||||||||
31 | Cost per child covered | |||||||||||||||||||||||||||||||||||||
32 | Cost per vitamin A supplement delivered | $ | input | - | $1.06 | $1.14 | $1.02 | $1.02 | $1.39 | $1.02 | $1.02 | $0.80 | $0.86 | $1.02 | $1.02 | $1.02 | $1.02 | $1.02 | $1.02 | $1.02 | $1.02 | $1.02 | $1.02 | $1.02 | $1.02 | $1.02 | $1.02 | $1.02 | $1.53 | $1.53 | $1.09 | $1.02 | ||||||
33 | Supplementation rounds delivered per year | # | input | 2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | ||||||
34 | Total cost per child receiving a year of vitamin A supplementation (VAS) | $ | calc | - | $2.11 | $2.27 | $2.03 | $2.03 | $2.79 | $2.03 | $2.03 | $1.60 | $1.72 | $2.03 | $2.03 | $2.03 | $2.03 | $2.03 | $2.03 | $2.03 | $2.03 | $2.03 | $2.03 | $2.03 | $2.03 | $2.03 | $2.03 | $2.03 | $3.05 | $3.05 | $2.18 | $2.03 | ||||||
35 | Upstream costs per child receiving a year of VAS | $ | calc | - | $1.34 | $1.46 | $1.28 | $1.28 | $1.82 | $1.28 | $1.28 | $0.99 | $1.07 | $1.28 | $1.28 | $1.28 | $1.28 | $1.28 | $1.28 | $1.28 | $1.28 | $1.28 | $1.28 | $1.28 | $1.28 | $1.28 | $1.28 | $1.28 | $2.14 | $2.14 | $1.53 | $1.42 | ||||||
36 | ||||||||||||||||||||||||||||||||||||||
37 | Outputs | |||||||||||||||||||||||||||||||||||||
38 | ||||||||||||||||||||||||||||||||||||||
39 | Total children covered | |||||||||||||||||||||||||||||||||||||
40 | Total people under age 5 receiving a year of VAS | # | calc | - | 744,706 | 687,004 | 779,777 | 779,777 | 550,904 | 779,777 | 779,777 | 1,013,443 | 936,448 | 779,777 | 779,777 | 779,777 | 779,777 | 779,777 | 779,777 | 779,777 | 779,777 | 779,777 | 779,777 | 779,777 | 779,777 | 779,777 | 779,777 | 779,777 | 468,083 | 468,083 | 655,609 | 702,125 | ||||||
41 | Baseline proportion of people under age 5 who receive VAS from non-campaign sources | % | input | - | 25% | 25% | 25% | 25% | 25% | 25% | 44% | 25% | 25% | 25% | 25% | 25% | 25% | 25% | 25% | 25% | 25% | 25% | 25% | 25% | 25% | 25% | 25% | 25% | 25% | 25% | 25% | 25% | ||||||
42 | Additional people under age 5 receiving a year of VAS as a result of the program | # | calc | - | 558,530 | 515,253 | 584,833 | 584,833 | 413,178 | 584,833 | 436,675 | 760,082 | 702,336 | 584,833 | 584,833 | 584,833 | 584,833 | 584,833 | 584,833 | 584,833 | 584,833 | 584,833 | 584,833 | 584,833 | 584,833 | 584,833 | 584,833 | 584,833 | 351,062 | 351,062 | 491,707 | 526,594 | ||||||
43 | ||||||||||||||||||||||||||||||||||||||
44 | Outcomes | |||||||||||||||||||||||||||||||||||||
45 | ||||||||||||||||||||||||||||||||||||||
46 | Mortality reduction among people under age 5 | |||||||||||||||||||||||||||||||||||||
47 | Reduction in all-cause mortality for children under age 5 participating in VAS programs found in the Imdad et al. 2017 meta-analysis | % | input | 24% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | ||||||
48 | Proportion of participating children that received VAS in the trials from the Imdad et al. 2017 meta-analysis | % | input | 87% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | ||||||
49 | Implied reduction in all-cause mortality for children under age 5 receiving vitamin A supplementation | % | calc | 27% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | ||||||
50 | Internal validity adjustment | % | input | -25% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | ||||||
51 | External validity adjustment | % | supp | - | -69% | -47% | -75% | -53% | -71% | -69% | -41% | -65% | -42% | -70% | -84% | -88% | -79% | -86% | -71% | -86% | -82% | -83% | -82% | -73% | -83% | -86% | -80% | -64% | -65% | -42% | -45% | -72% | ||||||
52 | Expected reduction in all-cause mortality among 6-59-month-olds receiving vitamin A supplementation | % | calc | - | 6.4% | 10.8% | 5.3% | 9.7% | 5.9% | 6.3% | 12.1% | 7.3% | 11.9% | 6.1% | 3.3% | 2.6% | 4.4% | 2.9% | 6.0% | 2.9% | 3.7% | 3.5% | 3.7% | 5.5% | 3.5% | 2.9% | 4.1% | 7.5% | 7.2% | 12.0% | 11.3% | 5.7% | ||||||
53 | Annual all-cause mortality rate among 6-59-month-olds in areas targeted for VAS | % | supp | - | 1.50% | 0.72% | 0.76% | 0.62% | 1.24% | 0.33% | 0.65% | 1.52% | 1.66% | 1.37% | 0.55% | 0.39% | 0.86% | 0.73% | 0.89% | 0.55% | 0.65% | 0.38% | 0.47% | 0.86% | 0.57% | 0.35% | 0.75% | 1.49% | 0.55% | 1.50% | 0.70% | 0.58% | ||||||
54 | Proportion of people under age 5 represented in GBD 2019 disease burden estimates who received VAS | % | input | - | 40% | 52% | 47% | 54% | 45% | 61% | 41% | 59% | 50% | 47% | 47% | 47% | 47% | 47% | 47% | 47% | 47% | 47% | 47% | 47% | 47% | 47% | 47% | 47% | 32% | 47% | 57% | 54% | ||||||
55 | All-cause mortality rate among 6-59-month-olds in the absence of VAS | % | calc | - | 1.54% | 0.76% | 0.78% | 0.65% | 1.28% | 0.35% | 0.69% | 1.59% | 1.76% | 1.41% | 0.56% | 0.40% | 0.88% | 0.74% | 0.92% | 0.56% | 0.66% | 0.39% | 0.48% | 0.88% | 0.58% | 0.36% | 0.77% | 1.54% | 0.56% | 1.59% | 0.75% | 0.60% | ||||||
56 | Total deaths averted among people under age 5 | # | calc | - | 553 | 424 | 239 | 371 | 313 | 128 | 365 | 878 | 1,475 | 503 | 108 | 60 | 227 | 127 | 319 | 95 | 143 | 79 | 103 | 283 | 118 | 60 | 184 | 676 | 141 | 670 | 416 | 179 | ||||||
57 | ||||||||||||||||||||||||||||||||||||||
58 | Long-term income increases for people under age 5 | |||||||||||||||||||||||||||||||||||||
59 | Ratio of value generated from income increases to value generated from mortalities averted among people under age 15 by seasonal malaria chemoprevention (SMC) | # | input | 0.31 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | ||||||
60 | Adjustment for income increases generated by VAS compared to SMC | % | input | -20% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | ||||||
61 | Ratio of value generated from income increases to value generated from mortalities averted among people under age 15 by VAS | # | calc | 0.25 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | ||||||
62 | Value assigned to averting a death of a person under age 5 with vitamin A supplementation | UoV | input | 119 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | ||||||
63 | Units of value generated from deaths averted among people under age 15 | UoV | calc | - | 65,702 | 50,322 | 28,432 | 44,070 | 37,219 | 15,250 | 43,327 | 104,191 | 175,084 | 59,733 | 12,878 | 7,092 | 26,922 | 15,032 | 37,879 | 11,228 | 16,945 | 9,425 | 12,259 | 33,642 | 14,016 | 7,153 | 21,864 | 80,277 | 16,757 | 79,546 | 49,398 | 21,279 | ||||||
64 | Units of value generated from long-term income increases | UoV | calc | - | 16,109 | 12,338 | 6,971 | 10,805 | 9,125 | 3,739 | 10,623 | 25,545 | 42,926 | 14,645 | 3,157 | 1,739 | 6,601 | 3,685 | 9,287 | 2,753 | 4,155 | 2,311 | 3,006 | 8,248 | 3,437 | 1,754 | 5,360 | 19,682 | 4,108 | 19,503 | 12,111 | 5,217 | ||||||
65 | 20% | |||||||||||||||||||||||||||||||||||||
66 | Value of outcomes | |||||||||||||||||||||||||||||||||||||
67 | ||||||||||||||||||||||||||||||||||||||
68 | Units of value from mortality reduction among people under age 5 | |||||||||||||||||||||||||||||||||||||
69 | Value assigned to averting a death of a person under age 5 with vitamin A supplementation | UoV | input | 119 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | ||||||
70 | Units of value from under-5 deaths averted (before accounting for leverage and funging) | UoV | calc | - | 65,702 | 50,322 | 28,432 | 44,070 | 37,219 | 15,250 | 43,327 | 104,191 | 175,084 | 59,733 | 12,878 | 7,092 | 26,922 | 15,032 | 37,879 | 11,228 | 16,945 | 9,425 | 12,259 | 33,642 | 14,016 | 7,153 | 21,864 | 80,277 | 16,757 | 79,546 | 49,398 | 21,279 | ||||||
71 | ||||||||||||||||||||||||||||||||||||||
72 | Units of value from long-term income increases for children age 14 and under | |||||||||||||||||||||||||||||||||||||
73 | Units of value generated from long-term income increases per person receiving a year of VAS | UoV | calc | - | 0.029 | 0.024 | 0.012 | 0.018 | 0.022 | 0.006 | 0.024 | 0.034 | 0.061 | 0.025 | 0.005 | 0.003 | 0.011 | 0.006 | 0.016 | 0.005 | 0.007 | 0.004 | 0.005 | 0.014 | 0.006 | 0.003 | 0.009 | 0.034 | 0.012 | 0.056 | 0.025 | 0.010 | ||||||
74 | Units of value from long-term income increases (before accounting for leverage and funging) | UoV | calc | - | 16,109 | 12,338 | 6,971 | 10,805 | 9,125 | 3,739 | 10,623 | 25,545 | 42,926 | 14,645 | 3,157 | 1,739 | 6,601 | 3,685 | 9,287 | 2,753 | 4,155 | 2,311 | 3,006 | 8,248 | 3,437 | 1,754 | 5,360 | 19,682 | 4,108 | 19,503 | 12,111 | 5,217 | ||||||
75 | ||||||||||||||||||||||||||||||||||||||
76 | Summary of outcomes and initial cost-effectiveness (before final adjustments) | |||||||||||||||||||||||||||||||||||||
77 | ||||||||||||||||||||||||||||||||||||||
78 | Summary of outcomes | |||||||||||||||||||||||||||||||||||||
79 | Total deaths averted among people under age 5 | # | feed | - | 553 | 424 | 239 | 371 | 313 | 128 | 365 | 878 | 1,475 | 503 | 108 | 60 | 227 | 127 | 319 | 95 | 143 | 79 | 103 | 283 | 118 | 60 | 184 | 676 | 141 | 670 | 416 | 179 | ||||||
80 | Additional people under age 5 receiving a year of VAS as a result of the program | # | feed | - | 558,530 | 515,253 | 584,833 | 584,833 | 413,178 | 584,833 | 436,675 | 760,082 | 702,336 | 584,833 | 584,833 | 584,833 | 584,833 | 584,833 | 584,833 | 584,833 | 584,833 | 584,833 | 584,833 | 584,833 | 584,833 | 584,833 | 584,833 | 584,833 | 351,062 | 351,062 | 491,707 | 526,594 | ||||||
81 | ||||||||||||||||||||||||||||||||||||||
82 | Value of individual outcomes | |||||||||||||||||||||||||||||||||||||
83 | Value assigned to averting a death of a person under age 5 with vitamin A supplementation | UoV | feed | 119 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | ||||||
84 | Units of value generated from long-term income increases per person receiving a year of VAS | UoV | feed | - | 0.029 | 0.024 | 0.012 | 0.018 | 0.022 | 0.006 | 0.024 | 0.034 | 0.061 | 0.025 | 0.005 | 0.003 | 0.011 | 0.006 | 0.016 | 0.005 | 0.007 | 0.004 | 0.005 | 0.014 | 0.006 | 0.003 | 0.009 | 0.034 | 0.012 | 0.056 | 0.025 | 0.010 | ||||||
85 | ||||||||||||||||||||||||||||||||||||||
86 | Total value of outcomes | |||||||||||||||||||||||||||||||||||||
87 | Units of value from under-5 deaths averted (before final adjustments) | UoV | calc | - | 65,702 | 50,322 | 28,432 | 44,070 | 37,219 | 15,250 | 43,327 | 104,191 | 175,084 | 59,733 | 12,878 | 7,092 | 26,922 | 15,032 | 37,879 | 11,228 | 16,945 | 9,425 | 12,259 | 33,642 | 14,016 | 7,153 | 21,864 | 80,277 | 16,757 | 79,546 | 49,398 | 21,279 | ||||||
88 | Units of value from long-term income increases (before final adjustments) | UoV | calc | - | 16,109 | 12,338 | 6,971 | 10,805 | 9,125 | 3,739 | 10,623 | 25,545 | 42,926 | 14,645 | 3,157 | 1,739 | 6,601 | 3,685 | 9,287 | 2,753 | 4,155 | 2,311 | 3,006 | 8,248 | 3,437 | 1,754 | 5,360 | 19,682 | 4,108 | 19,503 | 12,111 | 5,217 | ||||||
89 | ||||||||||||||||||||||||||||||||||||||
90 | Initial cost-effectiveness (before final adjustments) | |||||||||||||||||||||||||||||||||||||
91 | Total spending contributed by grantee | $ | feed | - | $1,000,000 | $1,000,000 | $1,000,000 | $1,000,000 | $1,000,000 | $1,000,000 | $1,000,000 | $1,000,000 | $1,000,000 | $1,000,000 | $1,000,000 | $1,000,000 | $1,000,000 | $1,000,000 | $1,000,000 | $1,000,000 | $1,000,000 | $1,000,000 | $1,000,000 | $1,000,000 | $1,000,000 | $1,000,000 | $1,000,000 | $1,000,000 | $1,000,000 | $1,000,000 | $1,000,000 | $1,000,000 | ||||||
92 | Total units of value from all outcomes (before final adjustments) | UoV | calc | - | 81,811 | 62,659 | 35,403 | 54,875 | 46,344 | 18,989 | 53,949 | 129,736 | 218,010 | 74,378 | 16,036 | 8,831 | 33,523 | 18,717 | 47,166 | 13,981 | 21,100 | 11,736 | 15,264 | 41,891 | 17,453 | 8,907 | 27,224 | 99,959 | 20,865 | 99,048 | 61,509 | 26,497 | ||||||
93 | Units of value generated per dollar spent (before final adjustments) | UoV | calc | - | 0.082 | 0.063 | 0.035 | 0.055 | 0.046 | 0.019 | 0.054 | 0.130 | 0.218 | 0.074 | 0.016 | 0.009 | 0.034 | 0.019 | 0.047 | 0.014 | 0.021 | 0.012 | 0.015 | 0.042 | 0.017 | 0.009 | 0.027 | 0.100 | 0.021 | 0.099 | 0.062 | 0.026 | ||||||
94 | Value generated per dollar donated to GiveDirectly's unconditional cash transfer program | UoV | input | 0.003 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | ||||||
95 | Cost-effectiveness in terms of multiples of GiveDirectly's unconditional cash transfer program | xcash | calc | - | 24.4 | 18.7 | 10.6 | 16.4 | 13.8 | 5.7 | 16.1 | 38.7 | 65.0 | 22.2 | 4.8 | 2.6 | 10.0 | 5.6 | 14.1 | 4.2 | 6.3 | 3.5 | 4.6 | 12.5 | 5.2 | 2.7 | 8.1 | 29.8 | 6.2 | 29.5 | 18.3 | 7.9 | ||||||
96 | ||||||||||||||||||||||||||||||||||||||
97 | Proportion of impact attributed to different outcomes | |||||||||||||||||||||||||||||||||||||
98 | Proportion of total units of value attributed to mortality reduction among people under age 5 | % | calc | - | 80% | 80% | 80% | 80% | 80% | 80% | 80% | 80% | 80% | 80% | 80% | 80% | 80% | 80% | 80% | 80% | 80% | 80% | 80% | 80% | 80% | 80% | 80% | 80% | 80% | 80% | 80% | 80% | ||||||
99 | Proportion of total units of value attributed to long-term income increases | % | calc | - | 20% | 20% | 20% | 20% | 20% | 20% | 20% | 20% | 20% | 20% | 20% | 20% | 20% | 20% | 20% | 20% | 20% | 20% | 20% | 20% | 20% | 20% | 20% | 20% | 20% | 20% | 20% | 20% | ||||||
100 |